Will Novartis’ Alcon Overhaul Stop The Rot?
This article was originally published in Clinica
Executive Summary
Inadequate innovation, not enough investment and losing sight of customer needs - these are the mistakes Novartis acknowledged it made in the management of Alcon, and which has culminated in a lackluster performance by the eye care business in 2015.